Catalyst Wire Dossier Catalyst Wire Dossier

P2-VP8 subunit vaccine (trivalent rotavirus vaccine)

· PATH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for P2-VP8 subunit vaccine (trivalent rotavirus vaccine), covering 2021-04-09 to 2021-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India [Phase 3]

See pricing